One-layer Versus Two-layer Duct-to-mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy: A Randomized Clinical Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15006808

Enrollment

Unknown

Registered

2015-07-24

Start date

2015-08-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the disease need pancreaticoduodenectomy

Interventions

treatment group:one-layer duct-to-mucosa anastomosis one-layer duct-to-mucosa anastomosis is used for pancreaticojejunostomy after pancreaticoduodenectomy

Control group:two-layer duct-to-mucosa anastomosis one-layer duct-to-mucosa anastomosis is used for pancreaticojejunostomy after pancreaticoduodenectomy

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 18-80 years old; Patients must have undergone pancreaticoduodenectomy; Preoperative enhanced CT scan shows respectable or borderline resectable neoplasm, Without distal metastasis.

Exclusion criteria

Exclusion criteria: Patients who have had previous pancreatic body tail resection; people infected with HIV patients with severe cardiopulmonary function, liver and renal function infection without control or active infections; Pregnant patients.

Design outcomes

Primary

Measure	Time frame
postoperative pancreatic fistula(POPF) rate;	—

Secondary

Measure	Time frame
postoperative hospital stay time;anastomosis time;morbidity;reoperation rate;	—

Countries

China

Contacts

Public ContactXiaoping Geng

xp_geng@163.com+86 13956010132

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026